Archives

  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2020-08
  • 2020-07
  • 2018-07
  • br Bashash D Gha ari

    2022-09-17


    Bashash, D., Ghaffari, S., Zaker, F., Hezave, K., Kazerani, M., Ghavamzadeh, A., Alimoghaddam, K., Mosavi, S., Gharehbaghian, A., Vossough, P., 2012. Direct short-term cytotoxic effects of BIBR 1532 on acute promyelocytic leukemia U 46619 through induction of p21 coupled with downregulation of c-Myc and hTERT transcription. Cancer Investig. 30 (1), 57–64.
    Bashash, D., Zareii, M., Safaroghli-Azar, A., Omrani, M.D., Ghaffari, S.H., 2017b. Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells. Hematology 22 (6), 330–340. Bashash, D., Zareii, M., Safaroghli-Azar, A., Omrani, M.D., Ghaffari, S.H., 2017c. Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells. Hematology 1–11. Bharadwaj, U., Marin-Muller, C., Li, M., Chen, C., Yao, Q., 2011. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression. Mol. Cancer 10 (1), 106.
    A. Pourbagheri-Sigaroodi et al.
    Ghaffari, S., Shayan-Asl, N., Jamialahmadi, A., Alimoghaddam, K., Ghavamzadeh, A., 2008. Telomerase activity and telomere length in patients with acute promyelocytic leukemia: indicative of proliferative activity, disease progression, and overall sur-vival. Ann. Oncol. 19 (11), 1927–1934.
    Ghaffari, S.H., Momeny, M., Bashash, D., Mirzaei, R., Ghavamzadeh, A., Alimoghaddam, K., 2012. Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcription. Hematology 17 (4), 198–206.
    A. Pourbagheri-Sigaroodi et al.